Insights provides context and perspective about key pharmacy trends and issues

Cost Management
Payors need ways to improve benefit management and reduce costs, but may hesitate due to concerns about impact on member satisfaction. A proactive member engagement strategy can ease... More
Briefing
The MS Care Challenge
Cost Management
MS is a chronic, progressive and unpredictable condition and each patient’s needs are unique. Caring for MS patients requires a holistic, tailored approach. More
Briefing
Expensive Pill
Cost Management
Value-based management can only deliver on their promise of incremental cost-savings if the right guardrails are in place to ensure appropriate utilization and management More
Briefing
24% Drop in Client Cost for Epinephrine Injectors
Cost Management
Despite triple digit price hikes, PBM trend management solutions helped lower the costs of epinephrine injectors 24% for clients for drugs covered under our Standard Control Formulary More
Commentary
Measuring Success
Cost Management
A few key metrics can help demonstrate how well a value-based management approach is working in helping align drug prices with the value and outcomes they deliver. More
Briefing
2018 Formulary Strategy Article
Cost Management
Formulary management is foundational in helping clients control costs. Value-based management strategies build upon the early success of formulary strategy for more targeted, precise... More
Commentary
Paying for Drugs Based on Outcomes
Cost Management
Value-based management seeks go beyond a static, pre-set price tag to uncover true value for drugs and better health for patients. More
Briefing
Aligning Drug Prices with Value
Cost Management
The current model of static, manufacturer-set drug prices is simply unsustainable. Value-based management approaches attempt to incentivize quality and efficacy. More
Briefing
Cost Management
New utilization management criteria ensure appropriate use of PCSK9 inhibitors, which can help lower bad cholesterol levels, but are significantly more expensive first-line therapies More
Briefing
Cost Management
Members may now face higher out-of-pocket costs for their prescriptions, particularly during their deductible phase. Payors can help by applying rebates at point-of-sale. More
Feature